首页 > 最新文献

Journal of Obstetrics and Gynaecology Research最新文献

英文 中文
A rare case of numerous parasitic myomas after laparoscopic myomectomy 腹腔镜子宫肌瘤切除术后出现大量寄生肌瘤的罕见病例。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-16 DOI: 10.1111/jog.16187
Kazuhisa Fujita, Kazuhiko Tsukada, Fumi Utsumi, Kazuhiro Sugihara, Makoto Urano, Kiyosumi Shibata

Parasitic myoma is a relatively rare disease in which one or more leiomyomas form outside the uterus; however, the detailed causes are unknown. Few sporadic reports are available, and per our research, the maximum number of parasitic myomas reported to date was 26, and almost all cases were treated by surgical resection. We report a rare case of numerous parasitic myomas in the abdominal cavity, possibly including an intrathoracic lesion, which could not be resected completely. The patient was a 42-year-old, gravid 2, para 0, artificially aborted 2, and not yet menopausal woman. She had undergone laparoscopic myomectomy at a different hospital 6 years prior. Laparoscopically, numerous hard white masses, ranging from 1 mm to approximately 55 mm in size, were found in the abdominal cavity. The masses were particularly numerous in the omentum and mesentery but were also found on the diaphragm, abdominal peritoneum, and intestinal surface. The patient was pathologically diagnosed with multiple benign leiomyomas. On computed tomography, a similar nodule was observed in the right lower lobe of the lung. Despite using in-bag morcellation, as in this case, numerous parasitic myomas occurred, suggesting that greater caution should be exercised when explaining laparoscopic myomectomy to patients.

寄生性子宫肌瘤是一种相对罕见的疾病,患者会在子宫外形成一个或多个子宫肌瘤,但具体原因不明。根据我们的研究,迄今为止报告的寄生性肌瘤最多为 26 例,几乎所有病例都是通过手术切除治疗的。我们报告了一例罕见的腹腔多发性寄生性肌瘤病例,可能包括胸腔内病变,但无法完全切除。患者是一名 42 岁的妇女,2 次妊娠,0 停经,2 次人工流产,尚未绝经。6 年前,她在另一家医院接受了腹腔镜子宫肌瘤切除术。腹腔镜检查发现,腹腔内有许多白色硬块,大小从1毫米到约55毫米不等。这些肿块尤其多见于网膜和肠系膜,但在横膈膜、腹膜和肠表面也有发现。经病理诊断,患者患有多发性良性子宫肌瘤。在计算机断层扫描中,右肺下叶也发现了类似的结节。尽管在本病例中使用了囊内肌瘤剥除术,但还是出现了许多寄生性肌瘤,这表明在向患者解释腹腔镜肌瘤切除术时应更加谨慎。
{"title":"A rare case of numerous parasitic myomas after laparoscopic myomectomy","authors":"Kazuhisa Fujita,&nbsp;Kazuhiko Tsukada,&nbsp;Fumi Utsumi,&nbsp;Kazuhiro Sugihara,&nbsp;Makoto Urano,&nbsp;Kiyosumi Shibata","doi":"10.1111/jog.16187","DOIUrl":"10.1111/jog.16187","url":null,"abstract":"<p>Parasitic myoma is a relatively rare disease in which one or more leiomyomas form outside the uterus; however, the detailed causes are unknown. Few sporadic reports are available, and per our research, the maximum number of parasitic myomas reported to date was 26, and almost all cases were treated by surgical resection. We report a rare case of numerous parasitic myomas in the abdominal cavity, possibly including an intrathoracic lesion, which could not be resected completely. The patient was a 42-year-old, gravid 2, para 0, artificially aborted 2, and not yet menopausal woman. She had undergone laparoscopic myomectomy at a different hospital 6 years prior. Laparoscopically, numerous hard white masses, ranging from 1 mm to approximately 55 mm in size, were found in the abdominal cavity. The masses were particularly numerous in the omentum and mesentery but were also found on the diaphragm, abdominal peritoneum, and intestinal surface. The patient was pathologically diagnosed with multiple benign leiomyomas. On computed tomography, a similar nodule was observed in the right lower lobe of the lung. Despite using in-bag morcellation, as in this case, numerous parasitic myomas occurred, suggesting that greater caution should be exercised when explaining laparoscopic myomectomy to patients.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16187","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between alcohol consumption levels and pelvic inflammatory disease: Findings from the NHANES 2013–2020 酒精消费水平与盆腔炎之间的关系:2013-2020 年国家健康与人口调查(NHANES)结果。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-16 DOI: 10.1111/jog.16188
Daji Wang, Jianbo Xiong

Background and Aim

Pelvic inflammatory disease (PID) is a common and serious infection affecting women's reproductive health, which may result in severe consequences, such as infertility. This research is to investigate the association between alcohol consumption levels and the odds of PID prevalence, providing insights that could inform public health policies.

Methods and Results

The U.S. National Health and Nutrition Examination Survey (NHANES) 2013–2020 is the data source. Multivariate logistic regression analysis, trend analysis, and curve fitting were employed to examine the associations between alcohol consumption levels and the odds of PID prevalence. Regarding subgroup analysis, we utilized the stratified analysis and interaction test to investigate the robustness of this association. Compared with participants who never consumed alcohol, alcohol consumption increased the odds of PID prevalence. The odds of PID prevalence increased with the increase in the level of alcohol consumption. In the fully adjusted model, compared to non-drinkers, the odds ratios (OR) for PID were 1.89 (95% CI: 1.23–2.92) for mild drinkers, 1.94 (95% CI: 1.24–3.04) for moderate drinkers, and 2.01 (95% CI: 1.27–3.19) for heavy drinkers, indicating an increased prevalence of PID by 89, 94, and 101%, respectively. This association was consistently observed across the study population.

Conclusions

Alcohol consumption levels were positively related to the odds of PID prevalence among adult females in the United States. Our results indicate that reducing alcohol consumption and cultivating good living habits will likely help prevent PID in the general population.

背景与目的:盆腔炎(PID)是一种影响女性生殖健康的常见严重感染,可导致不孕等严重后果。本研究旨在调查饮酒水平与PID患病率之间的关系,为公共卫生政策提供见解。方法和结果:数据来源为2013-2020年美国国家健康与营养检查调查(NHANES)。采用多变量logistic回归分析、趋势分析和曲线拟合来检验饮酒水平与PID患病率之间的关系。在亚组分析方面,我们采用分层分析和相互作用检验来调查这种关联的稳健性。与从不饮酒的参与者相比,饮酒增加了PID患病率。随着饮酒量的增加,PID患病率增加。在完全调整后的模型中,与不饮酒者相比,轻度饮酒者患PID的比值比(OR)为1.89 (95% CI: 1.23-2.92),中度饮酒者为1.94 (95% CI: 1.24-3.04),重度饮酒者为2.01 (95% CI: 1.27-3.19),表明PID的患病率分别增加了89%、94%和101%。这种关联在研究人群中得到了一致的观察。结论:在美国,酒精消费水平与成年女性患PID的几率呈正相关。我们的研究结果表明,减少饮酒和培养良好的生活习惯可能有助于预防普通人群的PID。
{"title":"Association between alcohol consumption levels and pelvic inflammatory disease: Findings from the NHANES 2013–2020","authors":"Daji Wang,&nbsp;Jianbo Xiong","doi":"10.1111/jog.16188","DOIUrl":"10.1111/jog.16188","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aim</h3>\u0000 \u0000 <p>Pelvic inflammatory disease (PID) is a common and serious infection affecting women's reproductive health, which may result in severe consequences, such as infertility. This research is to investigate the association between alcohol consumption levels and the odds of PID prevalence, providing insights that could inform public health policies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods and Results</h3>\u0000 \u0000 <p>The U.S. National Health and Nutrition Examination Survey (NHANES) 2013–2020 is the data source. Multivariate logistic regression analysis, trend analysis, and curve fitting were employed to examine the associations between alcohol consumption levels and the odds of PID prevalence. Regarding subgroup analysis, we utilized the stratified analysis and interaction test to investigate the robustness of this association. Compared with participants who never consumed alcohol, alcohol consumption increased the odds of PID prevalence. The odds of PID prevalence increased with the increase in the level of alcohol consumption. In the fully adjusted model, compared to non-drinkers, the odds ratios (OR) for PID were 1.89 (95% CI: 1.23–2.92) for mild drinkers, 1.94 (95% CI: 1.24–3.04) for moderate drinkers, and 2.01 (95% CI: 1.27–3.19) for heavy drinkers, indicating an increased prevalence of PID by 89, 94, and 101%, respectively. This association was consistently observed across the study population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Alcohol consumption levels were positively related to the odds of PID prevalence among adult females in the United States. Our results indicate that reducing alcohol consumption and cultivating good living habits will likely help prevent PID in the general population.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142829040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral 特刊:第28届亚洲和大洋洲妇产科联合会大会,2024年5月16日至20日,韩国釜山。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16160
{"title":"Oral","authors":"","doi":"10.1111/jog.16160","DOIUrl":"10.1111/jog.16160","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S2","pages":"85-122"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16160","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenomyosis with uterine abscess formation treated by adenomyomectomy: A report of two cases 子宫腺肌瘤切除术治疗子宫腺肌症合并子宫脓肿形成2例报告。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16185
Daiki Hiratsuka, Chihiro Ishizawa, Rei Iida, Yamato Fukui, Mitsunori Matsuo, Masato Nishida, Masako Ikemura, Miyuki Harada, Osamu Wada-Hiraike, Yutaka Osuga, Yasushi Hirota

Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to antibiotics and occasionally requires surgical treatment, such as hysterectomy. However, hysterectomy should be avoided in patients who seek to preserve fertility. Herein, for the first time, we report two cases of uterine adenomyosis with abscess formation during assisted reproductive procedures that were successfully treated with adenomyomectomy, thereby preserving fertility. A history of repeated intrauterine procedures and infections was crucial in making an appropriate preoperative diagnosis. Adenomyomectomy can be an effective treatment for adenomyosis associated with abscess in patients who wish to preserve fertility.

子宫腺肌症是育龄妇女的常见病,会导致痛经、异常子宫出血、不孕和产科并发症。在极少数情况下,子宫腺肌症会导致脓肿形成,而脓肿对抗生素难治,偶尔需要手术治疗,如子宫切除术。然而,对于希望保留生育能力的患者,应避免切除子宫。在此,我们首次报告了两例在辅助生殖手术中伴有脓肿形成的子宫腺肌症患者,他们都成功地接受了腺肌瘤切除术,从而保留了生育能力。反复宫腔内手术和感染的病史对于做出适当的术前诊断至关重要。对于希望保留生育能力的子宫腺肌症伴脓肿患者来说,子宫腺肌症切除术是一种有效的治疗方法。
{"title":"Adenomyosis with uterine abscess formation treated by adenomyomectomy: A report of two cases","authors":"Daiki Hiratsuka,&nbsp;Chihiro Ishizawa,&nbsp;Rei Iida,&nbsp;Yamato Fukui,&nbsp;Mitsunori Matsuo,&nbsp;Masato Nishida,&nbsp;Masako Ikemura,&nbsp;Miyuki Harada,&nbsp;Osamu Wada-Hiraike,&nbsp;Yutaka Osuga,&nbsp;Yasushi Hirota","doi":"10.1111/jog.16185","DOIUrl":"10.1111/jog.16185","url":null,"abstract":"<p>Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to antibiotics and occasionally requires surgical treatment, such as hysterectomy. However, hysterectomy should be avoided in patients who seek to preserve fertility. Herein, for the first time, we report two cases of uterine adenomyosis with abscess formation during assisted reproductive procedures that were successfully treated with adenomyomectomy, thereby preserving fertility. A history of repeated intrauterine procedures and infections was crucial in making an appropriate preoperative diagnosis. Adenomyomectomy can be an effective treatment for adenomyosis associated with abscess in patients who wish to preserve fertility.</p>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organizational Session 特刊:第28届亚洲和大洋洲妇产科联合会大会,2024年5月16日至20日,韩国釜山。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16158
{"title":"Organizational Session","authors":"","doi":"10.1111/jog.16158","DOIUrl":"10.1111/jog.16158","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S2","pages":"8-14"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16158","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plenary 特刊:第28届亚洲和大洋洲妇产科联合会大会,2024年5月16日至20日,韩国釜山。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16157
{"title":"Plenary","authors":"","doi":"10.1111/jog.16157","DOIUrl":"10.1111/jog.16157","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S2","pages":"5-7"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16157","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
e-Poster 特刊:第28届亚洲和大洋洲妇产科联合会大会,2024年5月16日至20日,韩国釜山。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16161
{"title":"e-Poster","authors":"","doi":"10.1111/jog.16161","DOIUrl":"10.1111/jog.16161","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S2","pages":"123-285"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16161","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symposium 特刊:第28届亚洲和大洋洲妇产科联合会大会,2024年5月16日至20日,韩国釜山。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-12 DOI: 10.1111/jog.16159
{"title":"Symposium","authors":"","doi":"10.1111/jog.16159","DOIUrl":"10.1111/jog.16159","url":null,"abstract":"","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"50 S2","pages":"15-84"},"PeriodicalIF":1.6,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jog.16159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient awareness of long-term cardiovascular and metabolic disease risks after hypertensive disorders of pregnancy in Japan 日本妊娠期高血压疾病患者对长期心血管和代谢疾病风险的认识
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-11 DOI: 10.1111/jog.16183
Takafumi Ushida, Sho Tano, Seiko Matsuo, Kazuya Fuma, Kenji Imai, Hiroaki Kajiyama, Tomomi Kotani

Aim

Given the increasing recognition of the importance of postpartum follow-up care for women with a history of hypertensive disorders of pregnancy (HDP) to mitigate their future risk of cardiovascular and metabolic diseases, here we aimed to evaluate the current status of postpartum follow-up care in Japan and explore the challenges to its implementation.

Methods

A web-based survey was conducted using a smartphone application among postpartum women between March and May 2024 to assess their knowledge of HDP-related future risk and postpartum follow-up care.

Results

A total of 880 valid responses were obtained, 73 (8.3%) of which were from women with a history of HDP. Of them, 56.2% were aware of the heightened risk of cardiovascular disease and even fewer knew about the risks of metabolic syndrome (37.0%) and the preventive use of low-dose aspirin (12.3%); in fact, 31.5% reported receiving no information about their risk or preventive measures from healthcare providers. Furthermore, 43.8% did not consult specialists or attend regular checkups after their 1-month checkup. Among women with a history of HDP, those who received information and guidance were more likely to implement behavioral changes than those who did not.

Conclusions

Patient awareness level of HDP-related risk was low and the information provided by their healthcare professionals was insufficient, indicating that postpartum follow-up care in Japan is not satisfactory. This study highlights the need for improved educational strategies and systematic follow-up protocols to ensure that women are adequately informed and supported in managing their long-term health risks.

目的:鉴于人们越来越认识到有妊娠高血压病史(HDP)的妇女产后随访护理的重要性,以降低其未来患心血管和代谢疾病的风险,本研究旨在评估日本产后随访护理的现状,并探讨其实施的挑战。方法:于2024年3月至5月,通过智能手机应用程序对产后妇女进行基于网络的调查,评估其对hdp相关未来风险的了解程度及产后随访护理情况。结果:共获得880份有效回复,其中73份(8.3%)来自有HDP病史的女性。其中,56.2%的人知道心血管疾病的风险增加,更少的人知道代谢综合征的风险(37.0%)和预防性使用低剂量阿司匹林(12.3%);事实上,31.5%的人报告没有从医疗保健提供者那里获得有关其风险或预防措施的信息。此外,43.8%的人在1个月的体检后没有咨询专家或参加定期检查。在有HDP病史的女性中,接受信息和指导的女性比没有接受信息和指导的女性更有可能实施行为改变。结论:患者对hdp相关风险的认知水平较低,医护人员提供的信息不足,表明日本产后随访护理不理想。这项研究强调需要改进教育战略和系统的后续协议,以确保妇女在管理其长期健康风险方面得到充分的了解和支持。
{"title":"Patient awareness of long-term cardiovascular and metabolic disease risks after hypertensive disorders of pregnancy in Japan","authors":"Takafumi Ushida,&nbsp;Sho Tano,&nbsp;Seiko Matsuo,&nbsp;Kazuya Fuma,&nbsp;Kenji Imai,&nbsp;Hiroaki Kajiyama,&nbsp;Tomomi Kotani","doi":"10.1111/jog.16183","DOIUrl":"10.1111/jog.16183","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Given the increasing recognition of the importance of postpartum follow-up care for women with a history of hypertensive disorders of pregnancy (HDP) to mitigate their future risk of cardiovascular and metabolic diseases, here we aimed to evaluate the current status of postpartum follow-up care in Japan and explore the challenges to its implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A web-based survey was conducted using a smartphone application among postpartum women between March and May 2024 to assess their knowledge of HDP-related future risk and postpartum follow-up care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 880 valid responses were obtained, 73 (8.3%) of which were from women with a history of HDP. Of them, 56.2% were aware of the heightened risk of cardiovascular disease and even fewer knew about the risks of metabolic syndrome (37.0%) and the preventive use of low-dose aspirin (12.3%); in fact, 31.5% reported receiving no information about their risk or preventive measures from healthcare providers. Furthermore, 43.8% did not consult specialists or attend regular checkups after their 1-month checkup. Among women with a history of HDP, those who received information and guidance were more likely to implement behavioral changes than those who did not.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Patient awareness level of HDP-related risk was low and the information provided by their healthcare professionals was insufficient, indicating that postpartum follow-up care in Japan is not satisfactory. This study highlights the need for improved educational strategies and systematic follow-up protocols to ensure that women are adequately informed and supported in managing their long-term health risks.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11634531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of short-term ketogenic diet on sex hormones and glucose-lipid metabolism in overweight or obese patients with polycystic ovary syndrome 短期生酮饮食对超重或肥胖多囊卵巢综合征患者性激素和糖脂代谢的影响
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-11 DOI: 10.1111/jog.16178
Meng Li, Lisong Zhang, Xiaoyu Li, Yanzhong Zhao

Aim

This study evaluates the clinical effects of a ketogenic diet (KD) versus a traditional comprehensive intervention, including lifestyle changes and oral contraceptives, in overweight or obese polycystic ovary syndrome (PCOS) patients.

Methods

A retrospective analysis of 70 overweight/obese PCOS patients (body mass index [BMI] ≥24 kg/m2) treated between December 2022 and December 2023 was conducted. The patients were categorized into two groups based on their past treatment modality: Group 1 received a KD treatment (N = 35), and Group 2 underwent comprehensive intervention (N = 35), with both treatments lasting 3 months. Changes in body weight, BMI, sex hormone levels, glucose-lipid metabolism indicators, and liver and kidney function were compared.

Results

Both groups experienced significant reductions in body weight and BMI after treatment (p < 0.05), with the KD group showing a greater reduction (p < 0.05). luteinizing hormone (LH), LH/follicle-stimulating hormone (FSH), and total testosterone (TT) levels decreased significantly in both groups (p < 0.05). The KD treatment led to significant reductions in fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride (TG), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) (p < 0.05), while the comprehensive intervention resulted in decreased FBG and ALT, and increased high-density lipoprotein-cholesterol (HDL-c) (p < 0.05). Additionally, the KD group had a greater reduction in FBG, and showed decreases in TG and AST, which remained unchanged in the comprehensive intervention group (p < 0.05).

Conclusion

The short-term KD treatment provides significant weight loss and effectively improves hormone regulation and glucose-lipid metabolism in overweight or obese PCOS patients, offering a valuable therapeutic option for managing the condition.

目的:本研究评估生酮饮食(KD)与传统综合干预(包括生活方式改变和口服避孕药)对超重或肥胖多囊卵巢综合征(PCOS)患者的临床效果。方法:回顾性分析2022年12月至2023年12月收治的70例体重指数[BMI]≥24 kg/m2的超重/肥胖PCOS患者。根据既往治疗方式将患者分为两组:1组接受KD治疗(N = 35), 2组接受综合干预(N = 35),疗程均为3个月。比较体重、BMI、性激素水平、糖脂代谢指标、肝肾功能的变化。结果:两组患者治疗后体重和BMI均显著降低(p)。结论:短期KD治疗可显著减轻体重,有效改善超重或肥胖PCOS患者的激素调节和糖脂代谢,为控制病情提供了有价值的治疗选择。
{"title":"Impact of short-term ketogenic diet on sex hormones and glucose-lipid metabolism in overweight or obese patients with polycystic ovary syndrome","authors":"Meng Li,&nbsp;Lisong Zhang,&nbsp;Xiaoyu Li,&nbsp;Yanzhong Zhao","doi":"10.1111/jog.16178","DOIUrl":"10.1111/jog.16178","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study evaluates the clinical effects of a ketogenic diet (KD) versus a traditional comprehensive intervention, including lifestyle changes and oral contraceptives, in overweight or obese polycystic ovary syndrome (PCOS) patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective analysis of 70 overweight/obese PCOS patients (body mass index [BMI] ≥24 kg/m<sup>2</sup>) treated between December 2022 and December 2023 was conducted. The patients were categorized into two groups based on their past treatment modality: Group 1 received a KD treatment (<i>N</i> = 35), and Group 2 underwent comprehensive intervention (<i>N</i> = 35), with both treatments lasting 3 months. Changes in body weight, BMI, sex hormone levels, glucose-lipid metabolism indicators, and liver and kidney function were compared.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Both groups experienced significant reductions in body weight and BMI after treatment (<i>p</i> &lt; 0.05), with the KD group showing a greater reduction (<i>p</i> &lt; 0.05). luteinizing hormone (LH), LH/follicle-stimulating hormone (FSH), and total testosterone (TT) levels decreased significantly in both groups (<i>p</i> &lt; 0.05). The KD treatment led to significant reductions in fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride (TG), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) (<i>p</i> &lt; 0.05), while the comprehensive intervention resulted in decreased FBG and ALT, and increased high-density lipoprotein-cholesterol (HDL-c) (<i>p</i> &lt; 0.05). Additionally, the KD group had a greater reduction in FBG, and showed decreases in TG and AST, which remained unchanged in the comprehensive intervention group (<i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The short-term KD treatment provides significant weight loss and effectively improves hormone regulation and glucose-lipid metabolism in overweight or obese PCOS patients, offering a valuable therapeutic option for managing the condition.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16593,"journal":{"name":"Journal of Obstetrics and Gynaecology Research","volume":"51 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142813413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Obstetrics and Gynaecology Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1